Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
10/2003
10/08/2003EP1349564A2 Regulation of cellproliferation and differentiation using topically applied peptides
10/08/2003EP1349558A1 Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity
10/08/2003EP1349553A1 Dihydro-triterpenes in the treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain
10/08/2003EP1349550A1 Substituted-4-quinolones
10/08/2003EP1349546A2 Dissociated glucocorticoid receptor antagonists for the treatment of clucocorticoid associated side-effect
10/08/2003EP1349537A2 Skin care product containing retinoids and phytoestrogens in a dual compartment package
10/08/2003EP1214318B1 Imidazo[1,2-a]pyridine and pyrazolo[2,3-a]pyridine derivatives
10/08/2003EP1181285B1 3-(arylsulfonylamino)-tetrahydrofuran-3-carboxylic acid hydroxamides
10/08/2003EP0971725B1 Methods for treatment of scar tissue
10/08/2003EP0966245B1 Antimicrobial cosmetic compositions
10/08/2003EP0863740B1 Reduction of hair growth
10/08/2003EP0750628B1 Fibroblast growth factor-10
10/08/2003CN1447819A Human CYR 61
10/08/2003CN1447810A Bicyclo-pyrazoles active as kinase inhibitors,process for their prepn. and pharmaceutical compsns. comprising them
10/08/2003CN1447804A 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat VCAM-1 mediated disorders
10/08/2003CN1447799A Giphenyl derivatives and use thereof as integrin inhibitors
10/08/2003CN1447788A Process for prodn. of calcium pantothenate
10/08/2003CN1447681A Storage stable tretinoin and 4-hydroxy anisole contg. topical compsn.
10/08/2003CN1446580A Preparation of effective component from rhodiola crenulate
10/08/2003CN1446574A Chilblains medicine liquid
10/08/2003CN1446573A Per oral health products for blacking hairs and pilatory effect
10/08/2003CN1446560A Formula of Chinese herbal medicine providing pilatory effect and its preparation method
10/08/2003CN1446556A Medicine for treating acne
10/08/2003CN1446545A Externally applied agent for treating skin suppuration infection
10/08/2003CN1446541A Externally applied agent for treating psoriasis, acne tinea and diversified skin diseases with pruritus
10/08/2003CN1123564C Anti-inflammatory compounds
10/08/2003CN1123336C Liquid personal cleaning compsns. Which contain encapsulated lipophilic skin moisturizing agent comprised of relatively large droplets
10/07/2003US6630516 Application of an effective, non-toxic amount of at least one active ingredient that inhibits MMPs and promotes procollagen synthesis; especially a retinoid selected from retinol, retinal, retinoic acid, or a retinoic acid salt
10/07/2003US6630503 Cell adhesion inhibitors
10/07/2003US6630500 Treating angiogenic disorders
10/07/2003US6630492 Lymphocyte function antigen-1 antagonists
10/07/2003US6630483 Phenanthridine-N-oxides
10/07/2003US6630463 Heterocycle-containing carboxylic acid derivative and drug containing the same
10/07/2003US6630337 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/07/2003US6630177 Products extracted from a plant of the genus Commiphora, particularly the Commiphora mukul plant, extracts containing same and applications thereof, for example in cosmetics
10/07/2003US6630133 Hair gel;
10/07/2003CA2302436C Branched alkoxy-substituted 2-aminopyridines
10/07/2003CA2287552C Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction
10/07/2003CA2263957C Diarylmethyl piperazine derivatives as delta opioid agonists
10/07/2003CA2251003C New compounds, derivatives of n-aryl 2-hydroxyalkylamides
10/02/2003WO2003080673A1 Costimulatory molecule and its use
10/02/2003WO2003080625A1 Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
10/02/2003WO2003080624A2 Dithiolopyrrolone derivatives useful in the treatment of proliferative diseases
10/02/2003WO2003080611A1 Spiro derivatives and adhesion molecule inhibitors comprising the same as the active ingredient
10/02/2003WO2003080607A1 Novel alkoxypyridine-derivatives
10/02/2003WO2003080594A1 Substituted chroman derivatives having cytochrome p450rai inhibitory activity
10/02/2003WO2003080592A1 2-pyrone compounds and use thereof
10/02/2003WO2003080582A2 Fredericamycin derivatives
10/02/2003WO2003080581A1 Phenanthridinones as parp inhibitors
10/02/2003WO2003080579A1 Novel adamantane derivatives
10/02/2003WO2003080568A2 Probucol derivatives
10/02/2003WO2003080566A2 Hif hydroxylase inhibitors
10/02/2003WO2003080557A1 Substituted 4-aminocyclohexanols
10/02/2003WO2003080556A1 Amine derivative with potassium channel regulatory function, its preparation and use
10/02/2003WO2003080135A1 Therapeutic compositions comprising modified polysaccharides
10/02/2003WO2003080134A1 Wound dressing materials comprising chemically modified polysaccharides
10/02/2003WO2003080118A2 Combination of an aldosterone receptor antagonist and a fibric acid derivative
10/02/2003WO2003080116A1 Modulating angiogenesis
10/02/2003WO2003080110A1 Topical pathogenic-tissue-destroying liquid
10/02/2003WO2003080105A2 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof
10/02/2003WO2003080071A1 Novel therapeutical use of agonist ligands specific to g2a receptor
10/02/2003WO2003080070A2 Combination comprising an hmg-coa reductase inhibittor and an insulin secretor enhancer or an insulin sensitizer
10/02/2003WO2003080069A1 Combination of an aldosterone receptor antagonist and a bile acid sequestering agent
10/02/2003WO2003080068A1 Combination of an aldosterone receptor antagonist and nicotinic acid or a nicotinic acid derivative
10/02/2003WO2003080064A1 Kinase inhibitors
10/02/2003WO2003080058A1 Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors
10/02/2003WO2003080054A1 Use of pyridyl amides as inhibitors of angiogenesis
10/02/2003WO2003080053A1 Combination treatments for chemokine-mediated diseases
10/02/2003WO2003080049A1 (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
10/02/2003WO2003080025A1 Topical composition based on ion-exchange resins, in particular for treating erythemas
10/02/2003WO2003080014A1 Two-phase cosmetic or dermatological preparations
10/02/2003WO2003079969A2 Compositions and methods for treating and preventing necrosis
10/02/2003WO2003079963A2 Homeopathic modular complex
10/02/2003WO2003079786A1 Dihydronepetalactone as insect repellent
10/02/2003WO2003079750A2 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF
10/02/2003WO2003053358A3 Fused heterocyclic compounds and analogs thereof: modulators of nuclear hormone receptor function
10/02/2003WO2003049715A3 Talc-containing cosmetic cleansing emulsion
10/02/2003WO2003043669A8 Composition and method for treatment of wounds
10/02/2003WO2003042173A8 Nk1 antagonists
10/02/2003WO2003030811A3 Use of ganoderic acids as cosmetic agents
10/02/2003WO2003028692A3 Acne treatment using oleanolic acid
10/02/2003WO2003015692A3 Crystallized glucocorticoid receptor ligand binding domain polypeptide and screening methods employing same
10/02/2003WO2003003992A3 Hair lotion stimulating hair growth
10/02/2003WO2002092759A3 Molecules for disease detection and treatment
10/02/2003WO2002087534A3 Cosmetic or dermatological formulations having a content of sericoside
10/02/2003WO2002074323A3 Using neural thread proteins to treat tumors and other hyperproliferative disorders
10/02/2003WO2002026781A3 Ige receptor antagonists
10/02/2003WO2002022573A3 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies
10/02/2003US20030187276 Hydrophobic polyamine analogs and methods for their use
10/02/2003US20030187257 Phosphodiesterase inhibitor; antiinflammatory agnets, autoimmune disease; antihistamine agents; skin disorders
10/02/2003US20030187226 Process of high purity albumin production
10/02/2003US20030187073 Disinfectant agent
10/02/2003US20030187069 Treatment of burns
10/02/2003US20030187052 Controrlling concentration of tumor necrosis factor, phosphodiesterase inhibitor; controlling cell differentiation, proliferation; antiinflammatory agents; cardiovascular disorders
10/02/2003US20030187040 2-Ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents
10/02/2003US20030187036 Use of biguanide derivatives for making a medicine having a wound healing effect
10/02/2003US20030187034 Composition containing at least one aryl oxime and at least one active substance for treating acne and the use thereof
10/02/2003US20030187024 Vision disorders; antiinflammatory agents; autoimmune disease; anticancer qgents; skin disorders
10/02/2003US20030187020 Chemical compounds
10/02/2003US20030187009 Analgesics, diarrhea, anticonvulsants, antitussive agents or drug abuse therapy
1 ... 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 ... 1065